Fluoroscopy Equipment Market

Market Definition

Fluoroscopy equipment involves the generation, transmission, and real-time detection of X-ray beams to create dynamic and continuous images of internal body structures, enabling precise visualization for diagnostic, interventional, and surgical procedures across various medical specialties. 

The market encompasses various types of fluoroscopy devices, including fixed and mobile systems, with advancements focusing on improved image quality, reduced radiation exposure, and integration with digital technologies. 

This report explores key drivers of market development, offering a detailed regional analysis and a comprehensive overview of the competitive landscape shaping future opportunities.

Fluoroscopy Equipment Market Overview

The global fluoroscopy equipment market size was valued at USD 6.23 billion in 2024 and is projected to grow from USD 6.53 billion in 2025 to USD 9.43 billion by 2032, exhibiting a CAGR of 5.39% during the forecast period. 

This growth is attributed to the rising adoption of fluoroscopy equipment across key medical specialties such as cardiology, orthopedics, urology, and interventional radiology. 

Increasing demand for real-time imaging during minimally invasive procedures and the growing prevalence of chronic diseases like cardiovascular disorders and gastrointestinal conditions are driving the growth of advanced fluoroscopy systems.

Major companies operating in the fluoroscopy equipment industry are Koninklijke Philips N.V., Siemens Healthcare Private Limited, Hologic, Inc., Shimadzu Corporation, GE HealthCare, Genoray Co., ltd., Stephanix, Ziehm Imaging GmbH, Carestream Health, Orthoscan Inc., CANON MEDICAL SYSTEMS CORPORATION, Agfa-Gevaert Group, Medtronic, Italray, and SternMed GmbH.

Growing emphasis on enhancing diagnostic accuracy, reducing radiation exposure, and improving procedural efficiency is fueling market expansion. 

Additionally, ongoing advancements in digital fluoroscopy, the integration of artificial intelligence (AI) for image enhancement and workflow automation, and increased investments in healthcare infrastructure, especially in developing regions are accelerating the development of the market.

• In December 2024, Siemens Healthineers introduced the Luminos Q.namix at RSNA 2024, a versatile system that combines fluoroscopy and radiography in one platform. It features AI-enabled workflow automation, and integrated dose-reduction technologies, along with remote and tableside operation modes for enhancing imaging efficiency and reducing operational costs.

Key Highlights

1. The fluoroscopy equipment market size was valued at USD 6.23 billion in 2024.
2. The market is projected to grow at a CAGR of 5.39% from 2025 to 2032.
3. North America held a market share of 38.69% in 2024, with a valuation of USD 2.41 billion.
4. The X-ray segment garnered USD 3.31 billion in revenue in 2024.
5. The cardiovascular segment is expected to reach USD 2.93 billion by 2032.
6. The ambulatory surgical centers segment is anticipated to witness the fastest CAGR of 6.55% over the forecast period.
7. Asia Pacific is anticipated to grow at a CAGR of 6.04% through the projection period.

Market Driver

Increasing Prevalence of Chronic Diseases

The market is propelled by the increasing prevalence of chronic diseases such as cardiovascular disorders, gastrointestinal conditions, and orthopedic ailments. 

These long-term health issues are becoming more widespread due to aging populations, sedentary lifestyles, and unhealthy dietary patterns, which create a sustained need for advanced diagnostic and interventional imaging solutions such as fluoroscopy equipment.

• In 2024, according to the World Health Organization (WHO), noncommunicable diseases (NCDs) such as cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes are responsible for over 70% of global deaths each year, rounding up to approximately 41 million deaths.

This is encouraging healthcare providers to adopt real-time imaging technologies that enable precise diagnosis, image-guided treatment, and the continuous monitoring of chronic conditions. Fluoroscopy systems are vital in procedures like angioplasty, catheter insertion, and joint repairs, where accuracy and patient safety are critical. 

The rising global prevalence of chronic diseases is driving hospitals, diagnostic centers, and outpatient facilities to invest in technologically advanced and low-radiation fluoroscopy systems, which fuel the expansion of the global market.

Market Challenge

Radiation Exposure Risks

Radiation exposure risks pose significant challenges to the growth of the fluoroscopy equipment market, as healthcare providers and patients remain concerned about the long-term health effects of ionizing radiation. 

Despite advancements in imaging technology, procedures involving fluoroscopy are still associated with cumulative radiation doses that can increase the risk of tissue damage and other adverse outcomes. 

Apprehension surrounding radiation safety, especially in pediatric and repeat patients, contributes to cautious adoption and may lead clinicians to favor alternative imaging modalities with lower or no radiation exposure. This can hinder the broader utilization of fluoroscopy systems and limit their application in certain clinical scenarios.

To address these challenges, manufacturers are developing next-generation systems equipped with low-dose imaging technologies, real-time dose monitoring, and automatic exposure control to reduce radiation levels without compromising image clarity. 

Healthcare institutions are also investing in staff training, safety certifications, and radiation protection measures like shielding and protective gear. Regulatory bodies and medical associations are promoting standardized radiation safety protocols and public awareness campaigns to educate clinicians and patients, thereby building confidence in the safe use of fluoroscopy equipment.

• In May 2025, Philips launched its “Engineering safety at the source” initiative to reduce X-ray exposure for patients and medical staff. The approach integrates innovations like ClarityIQ for dose reduction, LumiGuide with FORS for radiation-free navigation, DoseAware for real-time monitoring, and EchoNavigator for precise image fusion, which enhances safety and workflow efficiency while supporting ALARA (As Low As Reasonably Achievable) standards.

Market Trend

Adoption of Flat‑Panel Detectors (FPDs) over Image Intensifiers

The adoption of flat-panel detectors over conventional image intensifiers is transforming the market by improving imaging performance, efficiency, and safety. 

FPDs offer superior image quality with higher spatial resolution, reduced distortion, and enhanced sensitivity to low-dose radiation, enabling accurate diagnostics while minimizing exposure risks for patients and healthcare providers. Their compact design allows for more ergonomic and space-efficient system configurations, supporting greater flexibility in clinical environments. 

These advancements contribute to faster image acquisition, streamlined workflows, and improved integration with digital health systems, making FPD-based fluoroscopy systems more appealing to healthcare institutions. 

Ongoing innovations in detector materials and image processing software continue to enhance the capabilities of FPD technology, driving widespread adoption and gradually replacing traditional image intensifier-based systems in developed and emerging healthcare markets.

• In November 2024, Detection Technology launched its expanded flat-panel detector (FPD) portfolio for global sales, featuring over 60 X-ray FPD models. The portfolio is optimized for medical use, including fluoroscopy, dental imaging, oncology, portable X-ray, and surgical imaging.

Fluoroscopy Equipment Market Report Snapshot

Segmentation	Details
By Product Type	C-arms, and X-ray
By Application	Cardiovascular, Orthopedic, Pain Management & Trauma, Neurology, Gastrointestinal, Urology, General Surgery, and Others
By End User	Hospitals, Ambulatory Surgical Centers, and Specialty Clinics & Others
By Region	North America: U.S., Canada, Mexico
	Europe: France, UK, Spain, Germany, Italy, Russia, Rest of Europe
	Asia-Pacific: China, Japan, India, Australia, ASEAN, South Korea, Rest of Asia-Pacific
	Middle East & Africa: Turkey, U.A.E., Saudi Arabia, South Africa, Rest of Middle East & Africa
	South America: Brazil, Argentina, Rest of South America

Market Segmentation

• By Product Type (C-arms, and X-ray): The x-ray segment earned USD 3.31 billion in 2024, due to its widespread use in diagnostic imaging and broad application across various medical specialties.
• By Application (Cardiovascular, Orthopedic, Pain Management & Trauma, Neurology, Gastrointestinal, Urology, General Surgery, and Others): The cardiovascular segment held a share of 30.00% in 2024, due to the rising prevalence of heart diseases and the growing use of fluoroscopy in minimally invasive cardiac procedures such as angiography and catheterization.
• By End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics & Others): The hospitals segment is projected to reach USD 5.83 billion by 2032, owing to the high volume of diagnostic and interventional procedures performed, along with increased investments in advanced imaging infrastructure and the availability of skilled medical professionals.

Fluoroscopy Equipment Market Regional Analysis

Based on region, the global market has been classified into North America, Europe, Asia Pacific, Middle East & Africa, and South America.

North America fluoroscopy equipment market share stood at 38.69% in 2024, valued at USD 2.41 billion. This dominance is attributed to North America’s advanced healthcare infrastructure, early adoption of cutting-edge fluoroscopy technologies, and the strong presence of established medical imaging equipment manufacturers. 

The growing demand for minimally invasive procedures, coupled with increasing incidences of chronic diseases like cardiovascular and orthopedic conditions is fueling market growth in the region. Robust investment in research and development along with favorable reimbursement policies and regulatory support are further driving the adoption of advanced fluoroscopy systems across hospitals and surgical centers. 

Moreover, ongoing technological innovations focused on dose reduction, image quality enhancement, and digital integration are strengthening the region’s leadership in the global market.

• In March 2025, Canon Medical Systems USA introduced the Adora DRFi system in the U.S. market after receiving FDA 510(k) clearance. This hybrid radiography and low-dose fluoroscopy solution features a ceiling-mounted X-ray tube and detector with 340° rotations, wireless CXDI-RF detector docking, inMotion auto-positioning, and optional remote control designed to improve workflow efficiency, increase operational flexibility, and reduce staff workload.

Asia-Pacific fluoroscopy equipment industry is set to record a CAGR of 6.04% over the forecast period. This growth is attributed to the rapid modernization of healthcare infrastructure, increasing government healthcare expenditure, and rising awareness about advanced medical imaging technologies across the region. 

The region’s large and aging population, coupled with the growing prevalence of chronic diseases, is boosting the demand for diagnostic and interventional procedures that rely on fluoroscopy equipment. 

Expanding access to healthcare services and the rising number of diagnostic centers and surgical facilities are further accelerating equipment adoption. Strategic partnerships between global manufacturers and regional distributors, along with initiatives to localize production and enhance affordability, are improving access to fluoroscopy systems.

• In February 2024, Philips India introduced the Zenition 90 Motorized mobile C-arm, delivering 25 kW of power, motorized movement, and intuitive table-side controls. With automated workflow features and an eco-conscious design, the system enhances imaging quality, operational efficiency, and clinician independence in surgical settings.

Regulatory Frameworks

• In the United States, the Food and Drug Administration (FDA) 21 CFR Part 892 regulates radiologic devices, including fluoroscopy systems. It ensures that imaging equipment meets safety, performance, and radiation dose standards to protect patients and operators.
• In the European Union, the Medical Device Regulation (MDR) (EU 2017/745) governs fluoroscopy equipment. It mandates rigorous clinical evaluations, performance testing, and labeling requirements to ensure safety and effectiveness in medical imaging devices.
• In Japan, the Pharmaceutical and Medical Device Act (PMD Act) regulates fluoroscopy equipment. It requires product registration, pre-market approval, and adherence to technical and safety standards to ensure public health protection.

Competitive Landscape

The fluoroscopy equipment market comprises a balanced mix of established global manufacturers and emerging regional players, who aim to enhance their technological offerings and expand their market reach through innovation, strategic partnerships, and market penetration efforts. 

Market participants are investing significantly in research and development to improve system capabilities, including advanced imaging quality, radiation dose reduction, digital integration, and workflow automation, with a focus on creating flexible and high-performance solutions for diverse clinical applications. 

They are also introducing cost-effective mobile systems to address the increasing demand from large medical institutions and smaller healthcare facilities.

Companies are collaborating with technology providers, service organizations, and regional distributors to accelerate product adoption, ensure regulatory compliance, and provide tailored solutions that meet the evolving needs of healthcare systems across different geographies.

• In March 2025, NVIDIA partnered with GE HealthCare to advance autonomous diagnostic imaging using AI. Using NVIDIA’s Isaac for Healthcare platform, the partnership aims to automate tasks like patient positioning and image quality checks, accelerating the development of intelligent X-ray and ultrasound systems.

List of Key Companies in Fluoroscopy Equipment Market:

• Koninklijke Philips N.V.
• Siemens Healthcare Private Limited
• Hologic, Inc.
• Shimadzu Corporation
• GE HealthCare
• Genoray Co., Ltd.
• Stephanix
• Ziehm Imaging GmbH
• Carestream Health
• Orthoscan Inc.
• CANON MEDICAL SYSTEMS CORPORATION
• Agfa-Gevaert Group
• Medtronic
• Italray
• SternMed GmbH

Recent Developments (M&A/Product Launch)

• In September 2024, Siemens Healthineers launched the Ciartic Move self-driving mobile C-arm, designed to streamline 2D fluoroscopic and 3D cone-beam CT imaging in surgical settings. With automated positioning, remote control, and memory for up to 12 positions, the system enhances efficiency and consistency, cutting procedure times by up to 50% in spine and 55% in pelvic surgeries.
• In January 2023, Radon Medical Imaging acquired Premier Imaging Medical Systems to broaden its service capabilities and strengthen its presence in the southeastern U.S. The acquisition enhances Radon’s expertise in servicing fluoroscopy and radiography equipment.